Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synapsin III gene polymorphisms and schizophrenia.

O Ohmori1, T Shinkai, H Hori

  • 1Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. o-ohmori@med.uoeh-u.ac.jp

Neuroscience Letters
|February 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.

Japanese journal of cancer research : Gann·2000
Same author

Multifocal micronodular pneumocyte hyperplasia in a postmenopausal woman with tuberous sclerosis.

Virchows Archiv : an international journal of pathology·2000
Same author

New efficient chiral derivatizing agent, alpha-cyano-alpha-fluoro(2-naphthyl)acetic acid (2-CFNA). application to the EE determination of (-)-3-acetoxy-2-fluoro-2-(hexadecyloxymethyl)propan-1-ol.

Chirality·2000
Same author

Appendiceal intussusception induced by tubulovillous adenoma with carcinoma in situ: report of a case.

Surgery today·2000
Same author

Morphological change in the MNNG-treated rat gastric mucosa.

The Kurume medical journal·2000
Same author

[An investigation on ethylene oxide sterilization management in medical institutions].

Sangyo eiseigaku zasshi = Journal of occupational health·2000

Genetic analysis of synapsin III gene polymorphisms did not reveal a significant association with schizophrenia. These findings suggest that synapsin III gene variations do not increase susceptibility to schizophrenia.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Synapsins are key phosphoproteins in synaptic vesicle function, crucial for neurotransmission.
  • Synaptic dysfunction is implicated in schizophrenia pathophysiology.
  • The synapsin III gene locus (22q12-13) is a candidate region for schizophrenia susceptibility.

Purpose of the Study:

  • To investigate the potential genetic association between synapsin III gene polymorphisms and schizophrenia.
  • To determine if specific polymorphisms (-631C/G and -196G/A) are linked to schizophrenia risk.

Main Methods:

  • Case-control study design.
  • Genotyping of synapsin III gene polymorphisms (-631C/G and -196G/A).
  • Analysis of genetic association in 160 schizophrenic patients and 153 healthy controls.

Related Experiment Videos

Main Results:

  • No significant association was found between the synapsin III -631C/G polymorphism and schizophrenia.
  • No significant association was observed between the synapsin III -196G/A polymorphism and schizophrenia.
  • Neither polymorphism showed a significant association with schizophrenia diagnostic subtypes.

Conclusions:

  • The studied synapsin III gene polymorphisms do not appear to confer an increased susceptibility to schizophrenia.
  • These genetic variations are unlikely to be major risk factors for schizophrenia in the studied population.
  • Further research may explore other genetic or environmental factors in schizophrenia etiology.